REQUEST A DEMO
Total
USD $0.00
Search more companies

Arthromed S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Arthromed S.A. Profile Updated: August 02, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Arthromed S.A. is based in Ecuador. The head office is in Guayaquil. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on August 17, 2020. It currently has a total number of 2 (2022) employees. The company’s latest financial report indicates a net sales revenue drop of 30.57% in 2022. Over the same period, its total assets grew by 184.68%. The enterprise’s net profit margin increased by 5.89% in 2022.

Headquarters
Cooperativa Renacer, Mz 137
Guayaquil; Guayas;

Contact Details: Purchase the Arthromed S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Arthromed S.A. report to view the information.
Outstanding Shares:
Purchase the Arthromed S.A. report to view the information.
Registered Capital:
Purchase the Arthromed S.A. report to view the information.
Incorporation Date:
August 17, 2020
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Arthromed S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-30.57%
Total operating revenue
-30.57%
Operating profit (EBIT)
-60.4%
Net Profit (Loss) for the Period
1118.74%
Total assets
184.68%
Total equity
157.81%
Operating Profit Margin (ROS)
-38.17%
Net Profit Margin
5.89%
Return on Equity (ROE)
48.26%
Quick Ratio
-8.19%
Cash Ratio
-9.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?